| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |